Phayronet Research of Drug Delivery Medicines to Sick Cells

Share Article

The Phayronet project is engaged in technological development with the objective of delivering various medicines to sick cells. This month, Phayronet laboratories get ISO 17025 standard.



Prof Alexander Seifalian, UCL Centre for Nanotechnology & Regenerative MedicineThe Phayronet project is engaged in the technological development, whose key objective is to deliver various medicines to the sick cells.

Phayronet laboratories get this month ISO 17025 standard. It is the single most important standard for calibration and testing laboratories around the world. Moreover, the scientists finished this month the development of ceramic materials possessing special electric, optic and chemical traits. This is alongside the ability to manufacture pure and high quality level hydrogen fuel by means of splitting water into hydrogen and oxygen. The goal and subject matter of the Phayronet research is to develop brand new technologies in order to produce solar fuels, which could replace oil, or, at least, lessen our dependence on it. Besides, one of the project objectives is to reduce the emission of greenhouse gases into the atmosphere. The company laboratory deals with nanophotonic components in making tiny on-chip optical devices needed for optic communication media, sensors and simulation purposes.

The company works with the development of silicon-based nanomaterials. The latter are designated for biological sensors for further fast virulence identification in both food and water. This, along with rapid identification of pesticides that penetrated foodstuffs, is also meant for building silicon devices that would deliver anticancer drugs.

"The issue of interaction between current and domain walls is of great importance both for basic research and applications. This is due to the fact that current-induced manipulation of domain walls is one of the most promising routes to control magnetic configurations on the nano scale, which is needed in novel spintronic devices. "Prof. L. Klein's Lab.

Phayronet research is capable of packing nanoparticles of diverse types with DNA fragments. All these are inserted into cancer cells with the following purpose, namely: to apply nanoparticles as genetic material conductors that would mute the genes which have experienced a certain degree of mutation and which have consequently brought various diseases into the body. The general concept is to develop the novel trajectory control method through which all the problematic genes shall be tracked down, like the ones that are responsible for carcinogenesis.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Phayronet tech
+972 46317410
Email >

Follow >
Like >
Follow us on
Visit website